Profitability Ratios
| Ratio |
Value |
| GP Margin |
37.7% |
| EBIT Margin |
19.5% |
| EBITDA Margin |
25.7% |
| Operating Margin |
18.2% |
| Pretax Margin |
16.3% |
| Cont. Ops Margin |
15.1% |
| Net Margin |
15.1% |
| Bottom Line Margin |
15.0% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.89 |
| Quick Ratio |
1.53 |
| Solvency Ratio |
0.168 |
| Cash Ratio |
0.65 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
4.51 |
| Forward PEG |
4.51 |
| Price/Book |
4.08 |
| Price/Sales |
4.89 |
| Price/FCF |
34.62 |
| Price/Op Cash Flow |
27.87 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3703 |
| Debt/Equity |
0.7650 |
| Debt/Capital |
0.4334 |
| Long-Term Debt/Capital |
0.4017 |
| Financial Leverage |
2.07 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
3.99 |
| Operating Cash Flow Ratio |
0.515 |
| Operating Cash Flow/Sales |
17.5% |
| Free Cash Flow/Operating Cash Flow |
80.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.09 |
| Interest Coverage |
5.7146 |
| Short-Term Operating Cash Flow Coverage |
2.05 |
| Operating Cash Flow Coverage |
0.19 |
| Capital Expenditure Coverage |
5.13 |
| Dividend + Capital Expenditure Coverage |
3.62 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
9.4404% |
| Dividend Yield |
0.2919% |
| Dividend Yield % |
0.2919% |
| Dividend Per Share |
1.6915 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
118.50 |
| EPS |
17.918 |
| Debt/Share |
112.4309 |
| Cash/Share |
26.89 |
| Book Value/Share |
142.38 |
| Tangible BV/Share |
-31.02 |
| Equity/Share |
142.04 |
| Operating Cash Flow/Share |
20.793 |
| Capital Expenditure/Share |
4.056 |
| FCF/Share |
16.737 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.927 |
| Earnings Before Tax/EBIT |
0.896 |
| Price/Fair Value |
4.08 |
| Debt/Market Cap |
0.1820 |
| Effective Tax Rate |
7.5% |
| Enterprise Value Multiple |
21.71 |
TMO - Thermo Fisher Scientific Inc.